Magali Lacroix‐Triki

机构：Institut Gustave Roussy · ORCID：0000-0002-6641-8536

发表论文 282 篇 · 总被引 11613 次 · h-index 47

代表论文

• Patritumab deruxtecan in HR+HER2− advanced breast cancer: a phase 2 trial (2025 · Nature Medicine · 被引 25)
• Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial (2025 · The Lancet · 被引 16)
• Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides (2025 · Nature Communications · 被引 15)
• Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay (2025 · Journal of Clinical Oncology · 被引 9)
• Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers (2025 · Nature Communications · 被引 5)
• Evaluating AI-Based Mitosis Detection for Breast Carcinoma in Digital Pathology: A Clinical Study on Routine Practice Integration (2025 · Diagnostics · 被引 5)